default author photo

Vamsi Velcheti

New York University (NYU) - Thoracic Oncology Program

New York University (NYU) - Department of Hematology and Oncology

United States

SCHOLARLY PAPERS

2

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Deep Learning CT Signature Predicts Benefit from Immunotherapy in Metastatic NSCLC Independent of Standard Clinicopathological Markers

Number of pages: 32 Posted: 13 Jun 2022
University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Thoracic Imaging, University of Texas at Houston - Department of Thoracic Imaging, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Radiation Oncology, Stanford University - Department of Medicine, Stanford University - Department of Medicine, Baylor College of Medicine, Baylor University - Department of Medicine Epidemiology and Population Science, New York University (NYU) - Thoracic Oncology Program, Harvard University - Department of Radiology, Mayo Clinic - Florida - Division of Hematology and Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - Department of Imaging Physics, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center - Department of Biostatistics, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology and Stanford University - Department of Radiation Oncology
Downloads 97 (704,534)

Abstract:

Loading...

Non-small cell lung cancer (NSCLC), Immune Checkpoint Inhibitors (ICIs), Imaging biomarkers, Computed Tomography (CT), Deep learning, Survival analysis

2.

p53-Independent Epigenetic Treatment for Chemo-Refractory Small Cell Lung Cancer: Bio-Rationale and in vivo Proof-of-Principle

Posted: 14 Mar 2023
Cleveland Clinic - Department of Translational Hematology & Oncology Research, Cleveland Clinic - Department of Translational Hematology & Oncology Research, Cleveland Clinic - Department of Translational Hematology & Oncology Research, Cleveland Clinic - Department of Quantitative Health Sciences, Yale University - Department of Pathology, New York University (NYU) - Thoracic Oncology Program, Cleveland Clinic - Department of Translational Hematology & Oncology Research, National Institutes of Health - Developmental Therapeutics Branch, Fred Hutchinson Cancer Research Center, Cleveland Clinic - Department of Plastic Surgery, Government of the United States of America - Thoracic Epigenetics Section, New York University (NYU) - Thoracic Oncology Program, New York University (NYU) - Thoracic Oncology Program and Cleveland Clinic - Department of Translational Hematology & Oncology Research

Abstract:

Loading...

small cell lung cancer, Immune checkpoint blockade, Pyrimidine metabolism, Decitabine, 5azacytidine, Tetrahydrouridine.